Reports for TEVA-BUPRENORPHINE/NALOXONE

Brand name
TEVA-BUPRENORPHINE/NALOXONE

Company Name

TEVA CANADA LIMITED

Drug Identification Number

02453916

Ingredients & Strength

ATC Code

  • N07BC
  • N07BC

ATC Descriptor

  • DRUGS USED IN ADDICTIVE DISORDERS
  • DRUGS USED IN ADDICTIVE DISORDERS

Status

MARKETED
Shortage reports
Brand name Packaging size Status Date Created Date Updated Reports
ACT BUPRENORPHINE/NALOXONE 30 Resolved 2019-09-26 2020-01-24 94896
TEVA-BUPRENORPHINE/NALOXONE 30 Resolved 2022-12-01 2022-12-22 176824
TEVA-BUPRENORPHINE/NALOXONE 30 Resolved 2024-03-07 2024-06-27 221537
TEVA-BUPRENORPHINE/NALOXONE 30 Actual shortage 2025-08-29 2025-10-30 266199

Showing 1 to 4 of 4

Discontinuation reports
Brand name Packaging size Status Date Created Date Updated Reports

Showing 1 to 0 of 0